{{Rsnum
|rsid=2024513
|Gene=NRXN1
|Chromosome=2
|position=50924881
|Orientation=plus
|GMAF=0.2759
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NRXN1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.0 | 45.1 | 23.9
| HCB | 63.9 | 33.1 | 3.0
| JPT | 67.0 | 28.6 | 4.5
| YRI | 89.8 | 9.5 | 0.7
| ASW | 68.4 | 31.6 | 0.0
| CHB | 63.9 | 33.1 | 3.0
| CHD | 68.2 | 28.0 | 3.7
| GIH | 59.4 | 36.6 | 4.0
| LWK | 89.1 | 10.9 | 0.0
| MEX | 50.0 | 36.2 | 13.8
| MKK | 71.8 | 26.9 | 1.3
| TSI | 39.2 | 46.1 | 14.7
| HapMapRevision=28
}}[[rs2024513]] is a SNP in the neurexin-1 [[NRXN1]] gene on chromosome 2p16.3.

Based on a case-control study of 700+ Han Chinese patients with [[schizophrenia]], [[rs2024513]](A) was associated with higher risk, at an odds ratio of 1.3 (CI: 1.07 - 1.56, p=0.006).{{PMID|21477380|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}